Olympus launches HANAROSTENT Esophagus Through-the-Scope (TTS) stent

Cleansweep Live Auction Thursday Jan. 21th 10AM EST - Pre-Bid Now
California Auction Event Closing Jan. 26th - Bid Now

Olympus launches HANAROSTENT Esophagus Through-the-Scope (TTS) stent

Press releases may be edited for formatting or style | October 28, 2020 Cardiology

"We are pleased with the positive clinical feedback we have received from our trusted physician customers since our limited launch of HANAROSTENT Esophagus TTS in July," said Kevin Mancini, Vice President for Endoscopy at Olympus America Inc. "We are confident the HANAROSTENT Esophagus TTS will help our physician customers address quality of life issues in patients suffering from advanced gastrointestinal disease."

"Through our valued partnership with Olympus, the HANAROSTENT Esophagus TTS is the sixth stent successfully launched in the U.S. market in the past two years," said Jin-Hyung Park, CEO at M.I. Tech Co. Ltd. "We are thrilled to continue expanding capabilities of physicians in the U.S. and across the world, through the combination of a line of unparalleled stents and the trusted Olympus brand."

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.

About Olympus
Olympus is passionate about the solutions it creates for the medical, life sciences, and industrial equipment industries, as well as cameras and audio products.

Olympus' Medical business uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Olympus' Medical portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of endotherapy instruments.

About M.I. Tech
M.I. Tech Co., Ltd. develops, manufactures, and provides self-expandable metallic stents as a leading company in the field of interventional medicine. Since 1991 with its headquarters in Pyeongtaek, South Korea, the company has provided and upheld worldwide a superior standard of less invasive palliative treatment. By utilizing years of accumulated know-how and maintaining the global standard, our full range of gastrointestinal and airway stents are being manufactured under the strict quality management system, ISO 13485:2003, to satisfy the quality demands from our customers and to fulfill our mission, Create the Health.

SOURCE Olympus Medical Systems Group

Back to HCB News

You Must Be Logged In To Post A Comment